Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Matrix metalloproteinase 12, asthma, and COPD.

Literature DB >> 20018962

Matrix metalloproteinase 12, asthma, and COPD.

Guy G Brusselle.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2009 PMID： 20018962 DOI： 10.1056/NEJMe0910626

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

7 in total

1. The Rotterdam Study: 2014 objectives and design update.

Authors: Albert Hofman; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal: Eur J Epidemiol Date: 2013-11-21 Impact factor: 8.082

2. Chest circumference and birth weight are good predictors of lung function in preschool children from an e-waste recycling area.

Authors: Xiang Zeng; Xijin Xu; Yuling Zhang; Weiqiu Li; Xia Huo
Journal: Environ Sci Pollut Res Int Date: 2017-08-15 Impact factor: 4.223

3. First-in-Man Safety, Tolerability, and Pharmacokinetics of a Novel and Highly Selective Inhibitor of Matrix Metalloproteinase-12, FP-025: Results from Two Randomized Studies in Healthy Subjects.

Authors: Khalid Abd-Elaziz; Christine Voors-Pette; Kang-Ling Wang; Sandy Pan; Yisheng Lee; John Mao; Yuhua Li; Benjamin Chien; David Lau; Zuzana Diamant
Journal: Clin Drug Investig Date: 2020-12-17 Impact factor: 2.859

4. Circulating MMP-12 as Potential Biomarker in Evaluating Disease Severity and Efficacy of Sublingual Immunotherapy in Allergic Rhinitis.

Authors: Yandan Zhou; Min Xu; Wei Gong; Xiaoming Kang; Renzhong Guo; Jie Wen; Dinggang Zhou; Manjing Wang; Dazhi Shi; Qiancheng Jing
Journal: Mediators Inflamm Date: 2022-06-12 Impact factor: 4.529

Matrix metalloproteinase 12, asthma, and COPD.

1. The Rotterdam Study: 2014 objectives and design update.

2. Chest circumference and birth weight are good predictors of lung function in preschool children from an e-waste recycling area.

3. First-in-Man Safety, Tolerability, and Pharmacokinetics of a Novel and Highly Selective Inhibitor of Matrix Metalloproteinase-12, FP-025: Results from Two Randomized Studies in Healthy Subjects.

4. Circulating MMP-12 as Potential Biomarker in Evaluating Disease Severity and Efficacy of Sublingual Immunotherapy in Allergic Rhinitis.

Review 5. Matrix Metalloproteinases and Their Inhibitors in Pulmonary Fibrosis: EMMPRIN/CD147 Comes into Play.

Review 6. Current Understanding of Asthma Pathogenesis and Biomarkers.

7. Stage-dependent association of BDNF and TGF-β1 with lung function in stable COPD.